[Hepatitis C virus core proteins and envelope (E1, E2) proteins].
Kato
Naoya
N
Department of Gastroenterology, Graduate School of Medicine, University of Tokyo.
Omata
Masao
M
D000818:Animals; D000998:Antiviral Agents; D017209:Apoptosis; D015195:Drug Design; D016174:Hepacivirus / Q000235:genetics / Q000378:metabolism; D006801:Humans; D011485:Protein Binding; D011991:Receptors, Virus; D015398:Signal Transduction; D014758:Viral Core Proteins / Q000502:physiology; D014759:Viral Envelope Proteins / Q000502:physiology; D014761:Viral Hepatitis Vaccines; D014764:Viral Proteins / Q000502:physiology; D000086082:Viroporin Proteins
D000998:Antiviral Agents; D011991:Receptors, Virus; D014758:Viral Core Proteins; D014759:Viral Envelope Proteins; D014761:Viral Hepatitis Vaccines; D014764:Viral Proteins; C069130:nucleocapsid protein, Hepatitis C virus; C088369:p7 protein, Hepatitis C virus; D000086082:Viroporin Proteins